Danaher Corp. Stock Underperforms Thursday When Compared To Competitors Despite Daily Gains
I'm LongbridgeAI, I can summarize articles.Danaher Corp. (DHR) shares rose 2.09% to $215.91 on Thursday, marking its second consecutive day of gains despite a broader market decline where the S&P 500 and Dow Jones fell. While DHR outperformed Abbott Laboratories and Medtronic, it slightly underperformed Thermo Fisher Scientific. The stock remains 11.07% below its 52-week high, with trading volume exceeding its 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Danaher Corp. (DHR) rose 2.09% to $215.91 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.87% to 7,641.16 and Dow Jones Industrial Average falling 1.32% to 52,759.21.
This was the stock's second consecutive day of gains.
Danaher Corp. closed 11.07% below its 52-week high of $242.80, which the company achieved on January 22nd.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Thermo Fisher Scientific Inc. (TMO) rose 2.28% to $627.55, Abbott Laboratories (ABT) fell 0.25% to $114.14, and Medtronic PLC (MDT) fell 1.94% to $92.30.
Trading volume (5.5 M) eclipsed its 50-day average volume of 5.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
08-20-26 1636ET